Trial
NCT05083078
A Study of Guselkumab and Risankizumab in Healthy Participants and Participants With Psoriatic Arthritis
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Janssen Research & Development, LLC
Collaborators
—
Condition
Arthritis, Psoriatic
Intervention
Guselkumab
Why stopped
The study was stopped due to unanticipated feasibility constraints.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-07-26